SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-017879
Filing Date
2024-02-21
Accepted
2024-02-21 16:01:34
Documents
129
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rare-20231231.htm   iXBRL 10-K 4062259
2 EX-10.18 rare-ex10_18.htm EX-10.18 286838
3 EX-10.30 rare-ex10_30.htm EX-10.30 47643
4 EX-10.31 rare-ex10_31.htm EX-10.31 44064
5 EX-10.32 rare-ex10_32.htm EX-10.32 35217
6 EX-10.33 rare-ex10_33.htm EX-10.33 41844
7 EX-10.34 rare-ex10_34.htm EX-10.34 27071
8 EX-10.35 rare-ex10_35.htm EX-10.35 42257
9 EX-10.36 rare-ex10_36.htm EX-10.36 27875
10 EX-21.1 rare-ex21_1.htm EX-21.1 20921
11 EX-23.1 rare-ex23_1.htm EX-23.1 6272
12 EX-31.1 rare-ex31_1.htm EX-31.1 15028
13 EX-31.2 rare-ex31_2.htm EX-31.2 14507
14 EX-32.1 rare-ex32_1.htm EX-32.1 11432
15 EX-97.1 rare-ex97_1.htm EX-97.1 23551
16 GRAPHIC img215954057_0.jpg GRAPHIC 95411
17 GRAPHIC img215954057_1.jpg GRAPHIC 43763
  Complete submission text file 0000950170-24-017879.txt   17403760

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20231231.xsd EX-101.SCH 2208733
131 EXTRACTED XBRL INSTANCE DOCUMENT rare-20231231_htm.xml XML 3287689
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 24659279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)